Viewing Study NCT00416494


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2026-05-28 @ 5:28 AM
Study NCT ID: NCT00416494
Status: COMPLETED
Last Update Posted: 2014-09-03
First Post: 2006-12-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Sponsor: Herbert Hurwitz, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adenocarcinoma of the colon View
None recurrent colon cancer View
None stage IV colon cancer View
None adenocarcinoma of the rectum View
None recurrent rectal cancer View
None stage IV rectal cancer View